PLATINUM INVESTMENT MANAGEMENT LTD
Position in ADCT — ADC Therapeutics SA
CIK 1256071
SYDNEY AUSTRALIA 2000, C3
Position in ADCT
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$3,715,417
+$217,971 QoQ
Shares Held
990,778
0.0% QoQ
Ownership
0.779%
of shares outstanding
% of Portfolio
0.95%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ADCT Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026PLATINUM INVESTMENT MANAGEMENT LTD holds $8,680,237 across 2 Drug Manufacturers - Specialty & Generic names. ADCT ranks #2 (42.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
42,000 | $4,964,820 | |
| 2 | ADCT |
ADC Therapeutics SA
This page
|
990,778 | $3,715,417 |
All Filings in ADCT
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,715,417 | 990,778 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $3,497,446 | 990,778 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $4,626,884 | 1,156,721 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $3,717,870 | 1,387,265 | Shares | Sole | 2025-07-21 | |
| 2025-03-31 | $2,873,702 | 2,038,087 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $3,208,986 | 1,612,556 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $4,550,225 | 1,444,516 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $4,095,843 | 1,296,153 | Shares | Sole | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||